Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic Usefulness of LC-OCT in Mammary and Extramammary Paget Disease and Correlation With Vertical and Horizontal Histopathology: A Case Series.

The American Journal of dermatopathology·2026
Same author

Central sensitization across nociceptive, neuropathic, and mixed chronic pain: a multidimensional longitudinal study protocol integrating neurophysiological, cognitive, and psychological measures.

Pain management·2026
Same author

Wearable technologies in neurorehabilitation and cardiac rehabilitation: A narrative review.

Journal of bodywork and movement therapies·2026
Same author

Perception and reality: assessing the accuracy of self-assessed dysphonia and dysphagia risk in people with cardiovascular disease.

Postgraduate medicine·2026
Same author

Are emotions measurable? A narrative review on wearable technologies between neuroscience and cardiology.

Expert review of medical devices·2026
Same author

Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN Study.

Clinical and experimental dermatology·2026

Related Experiment Video

Updated: Jul 3, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

Kaposi sarcoma: a continuing conundrum.

Robert A Schwartz1, Giuseppe Micali, Maria Rita Nasca

  • 1Department of Dermatology, New Jersey Medical School, Newark, New Jersey 07103-2714, USA. roschwar@cal.berkeley.edu

Journal of the American Academy of Dermatology
|July 22, 2008
PubMed
Summary

Kaposi sarcoma (KS), a human herpesvirus-8 infection, presents varied risks from benign to life-threatening, particularly in AIDS patients and transplant recipients. Understanding its global prevalence and transmission is key to developing effective, non-immunosuppressive therapies and prevention strategies.

More Related Videos

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

Related Experiment Videos

Last Updated: Jul 3, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)
07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus
07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

Area of Science:

  • Oncology
  • Virology
  • Epidemiology

Background:

  • Kaposi sarcoma (KS) is a complex neoplastic disease with varying clinical presentations, ranging from benign classic/Mediterranean forms to life-threatening manifestations.
  • KS is etiologically linked to human herpesvirus-8 (HHV-8), which is a necessary but not sufficient cause of the disease.
  • The prevalence of KS and HHV-8 infection varies geographically, with low rates in the US/UK, intermediate in Italy/Greece, and high rates in parts of Africa.

Purpose of the Study:

  • To provide updated information on Kaposi sarcoma, emphasizing its diverse clinical contexts including classic, transplant-associated, and AIDS-related forms.
  • To detail the etiology and transmission patterns of Kaposi sarcoma and human herpesvirus-8 infection across different global populations.
  • To explore therapeutic strategies for KS, focusing on non-immunosuppressive approaches, and discuss novel prevention opportunities.

Main Methods:

  • Review of current literature on Kaposi sarcoma epidemiology, etiology, and clinical patterns.
  • Analysis of human herpesvirus-8 transmission dynamics in various geographic and patient populations.
  • Evaluation of therapeutic interventions for Kaposi sarcoma, including anti-herpesvirus therapies and sirolimus in transplant recipients.

Main Results:

  • Kaposi sarcoma presents distinct epidemiological patterns globally, influenced by factors such as geographic location and host immune status.
  • Human herpesvirus-8 is the causative agent, with transmission routes potentially involving blood-sucking insects in endemic areas.
  • Treatment challenges include managing KS without further compromising the patient's immune system, with emerging anti-viral therapies and specific immunosuppressants offering new avenues.

Conclusions:

  • Kaposi sarcoma remains a significant clinical challenge, requiring a nuanced understanding of its diverse presentations and risk factors.
  • Effective management and prevention of Kaposi sarcoma hinge on comprehending HHV-8 infection dynamics and developing targeted, non-immunosuppressive treatments.
  • Advances in anti-herpesvirus therapies and the use of agents like sirolimus offer promising new strategies for KS prevention and treatment, particularly in immunocompromised individuals.